[Federal Register: June 3, 2002 (Volume 67, Number 106)]
[Notices]               
[Page 38285-38286]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jn02-58]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Prospective Grant of Exclusive License: Systems and Methods for 
Aerosol Delivery of Agents

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 
CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention 
(CDC), Technology Transfer Office, Department of Health and Human 
Services (DHHS), is contemplating the grant of a worldwide exclusive 
license to practice the inventions embodied in the patent application 
referred to below to D. J. Schweihs of Nashville, Tennessee. The patent 
rights in these inventions have been assigned to the government of the 
United States of America. The patent application to be licensed is:
    Title: Systems and Methods for Aerosol Delivery of Agents. U.S. 
Patent Application Serial No. 60/276,539.
    Filing Date: 03/15/01.
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
    This invention comprises an aerosol vaccination system designed for 
the administration of measles vaccine. The device is a hand held, 
battery powered ultrasonic nebulizer which delivers vaccine to the 
respiratory tract via disposable nasal prongs. The prototype vaccine is 
measles; however, this device may be adapted for any vaccine suitable 
for respiratory administration.

ADDRESSES: Requests for a copy of the patent application, inquiries, 
comments, and other materials relating to the contemplated license 
should be directed to Andrew Watkins, Director, Technology Transfer 
Office, Centers for Disease Control and Prevention (CDC), 4770 Buford 
Highway, Mailstop K-79, Atlanta, GA 30341, telephone: (770)

[[Page 38286]]

488-8600; facsimile: (770) 488-8615. Applications for a license filed 
in response to this notice will be treated as objections to the grant 
of the contemplated license. Only written comments and/or applications 
for a license which are received by CDC within sixty days of this 
notice will be considered. Comments and objections submitted in 
response to this notice will not be made available for public 
inspection, and, to the extent permitted by law, will not be released 
under the Freedom of Information Act, 5 U.S.C. 552. A signed 
Confidential Disclosure Agreement will be required to receive a copy of 
any pending patent application.

    Dated: May 24, 2002.
James D. Seligman,
Associate Director for Program Services, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 02-13782 Filed 5-31-02; 8:45 am]
BILLING CODE 4163-18-P